Unknown

Dataset Information

0

Association Between Thrombogenicity Indices and Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction.


ABSTRACT: The association between thrombogenicity and coronary microvascular dysfunction (CMD) has been poorly explored in patients with acute myocardial infarction (AMI). In our real-world clinical practice (N = 116), thrombogenicity was evaluated with thromboelastography and conventional hemostatic measures, and CMD was defined as index of microcirculatory resistance of >40 U using the invasive physiologic test. High platelet-fibrin clot strength (P-FCS) (≥68 mm) significantly increased the risk of postprocedural CMD (odds ratio: 4.35; 95% CI: 1.74-10.89). Patients with both CMD and high P-FCS had a higher rate of ischemic events compared to non-CMD subjects with low P-FCS (odds ratio: 5.58; 95% CI: 1.31-23.68). This study showed a close association between heightened thrombogenicity and CMD and their prognostic implications after reperfusion in acute myocardial infarction patients.

SUBMITTER: Kang MG 

PROVIDER: S-EPMC8559320 | biostudies-literature | 2021 Sep-Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association Between Thrombogenicity Indices and Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction.

Kang Min Gyu MG   Koo Bon-Kwon BK   Tantry Udaya S US   Kim Kyehwan K   Ahn Jong-Hwa JH   Park Hyun Woong HW   Park Jeong Rang JR   Hwang Seok-Jae SJ   Hwang Jin-Yong JY   Gurbel Paul A PA   Samady Habib H   Koh Jin-Sin JS   Jeong Young-Hoon YH  

JACC. Basic to translational science 20210901 9-10


The association between thrombogenicity and coronary microvascular dysfunction (CMD) has been poorly explored in patients with acute myocardial infarction (AMI). In our real-world clinical practice (N = 116), thrombogenicity was evaluated with thromboelastography and conventional hemostatic measures, and CMD was defined as index of microcirculatory resistance of >40 U using the invasive physiologic test. High platelet-fibrin clot strength (P-FCS) (≥68 mm) significantly increased the risk of post  ...[more]

Similar Datasets

| S-EPMC5746201 | biostudies-literature
| S-EPMC11535225 | biostudies-literature
| S-EPMC7061278 | biostudies-literature
| S-EPMC8766347 | biostudies-literature
| S-EPMC10218901 | biostudies-literature
| S-EPMC9528029 | biostudies-literature
| S-EPMC5033815 | biostudies-literature
| S-EPMC6251819 | biostudies-literature
| S-EPMC9754025 | biostudies-literature
| S-EPMC9727929 | biostudies-literature